Fermentor growth of Bacteroides fragilis under controlled conditions in a complex medium containing 1% glucose and 10% fetal calf serum resulted in high yields of bacteria. After hot phenol-water extraction of the organisms, capsular polysaccharide was isolated from the aqueous phase and purified by Sephacryl S-300 chromatography in a buffer with 3% sodium deoxycholate. Lipopolysaccharide was isolated by phenol-chloroform-light petroleum ether extraction. The capsular polysaccharide from B. fragilis strain NCTC 9343 contained six sugars:
Bacterioides fragilis is the predominant organism isolated from cases of intraabdominal sepsis and is the most common blood culture isolate in patients with anaerobic bacteremia (5, 21) . This contrasts with the composition of the normal colonic flora, in which this organism is outnumbered by other Bacteroides species such as B. vulgatus and B. thetaiotaomicron (20) . B. fragilis is an organism which lives symbiotically with the host and can cause serious infection only under certain circumstances. Such circumstances include (i) fecal contamination of the peritoneum, (ii) abscesses in any of several organ systems, and (iii) soft tissue infections (5) . This clinical information suggested that a search for a virulence factor would be of value.
Studies during the 1970s detected two interesting surface polysaccharides (10, 11, 16) . One component was a capsular antigen, reported to be unique for B. fragilis, and the other was a lipopolysaccharide (LPS) which was chemically different from endotoxins of aerobic gram-negative bacteria and biologically impotent (6, 10) . The capsular polysaccharide had been shown to be an important virulence factor in the pathogenesis of experimental abscesses (13, 22) . The LPS demonstrated some of the same virulence properties at higher doses, but incomplete separation of the two antigens was thought to be a possible explanation for this phenomenon.
The chemical composition and the structures of the capsular polysaccharide and LPS from B. fragilis have been investigated, but results have varied (6, 10, 11, 14) . One reason for disparate results has been difficulty in obtaining sufficient quantities of purified antigen for chemical analysis and structural studies. Another reason is the decrease in the quantity of extractable capsular polysaccharide with serial in vitro passage of B. fragilis (14) , although it has been shown that animal passage maintains capsule production. The final difficulty in chemical analyses has been inability to determine the degree of separation of capsule from LPS. This was in part because of the lack of any of the readily identifiable carbohydrates unique to aerobic bacterial endotoxins in the B. fragilis LPS (6, 10) .
In (vol/vol) final concentration. Overnight cultures (100 ml) of the B. fragilis strains were grown in the same medium and were used to inoculate the fermentor. The organisms were then grown to late logarithmic phase at 37°C, with the pH maintained at 7.0. Nitrogen gas supplemented with 3% hydrogen and 5% carbon dioxide was bubbled through the medium during growth. All cultures were checked for purity at the end of the growth cycle under both aerobic and anaerobic conditions. After incubation, the organisms were collected by centrifugation (8,000 x g, 4°C, 20 min) and washed with 0.15 M NaCl.
Extraction and purification of the capsular polysaccharides. Pelleted organisms were suspended in water and extracted with phenol-water (29) . The aqueous phase was subsequently dialyzed for 4 days against tap water and overnight against distilled water. After lyophilization, the aqueous phase from the phenolwater extract was suspended in a buffer containing 3% sodium deoxycholate, pH 9.5 (0.05 M glycine-0.001 M EDTA-3% sodium deoxycholate). The pH was first raised with 5 (19) , with bovine serum albumin as standard. Amino acids and hexosamines were quanititated by using a Durrum D-500 amino acid analyzer (Dionex, Inc., Sunnyvale, Calif.). The presence of nucleic acids was determined as described earlier (18) . Analyses of the monosaccharide constituents were carried out by gas-liquid chromatography (GLC) after hydrolysis in 0.5 M trifluoroacetic acid at 100°C for 18 h, essentially as described by Sawardeker et al. (24) . The alditol acetates were analyzed on an SP 1000 wall-coated capillary column (25 m by 0.25 mm), using a Hewlett-Packard 5830A instrument equipped with a flame ionization detector at a 230°C oven temperature, and on 3% OV 225 on Gas-Chrom Q at 190°C, using a Perkin-Elmer 990 instrument with a flame ionization detector. All sugar residues were identified either by cochromatography with authentic standards or with GLC-mass spectrometry of the alditol acetates, using a Varian MAT 311 GLC-mass spectrometer fitted with an OV 225 or SP 1000 column.
The carboxyl groups of uronic acids in the capsular polysaccharides were reduced by the method of Taylor and Conrad (27) . The absolute configuration of monosaccharides was determined by GLC of the acetylated (+)-2-octyl-glycosides, as described by Leontein et al. (17) .
The 13C nuclear magnetic resonance spectra of the capsular polysaccharides were recorded for solutions in D20 at 85°C, using a Bruker WT-200 instrument.
The fatty acids were estimated as methyl esters after methanolysis as described by Wollenweber et al. (31) on an SE-30 wall-coated capillary column (25 m by 0.25 mm), using a Hewlett-Packard 5830a instrument at 170°C. Serological methods. Rabbit antisera against the B.
fragilis capsular polysaccharides and LPSs were prepared as described previously (11) . The enzyme-linked immunosorbent assay (ELISA) was performed as described earlier (18) . In ELISA inhibition experiments, serum was preincubated for 1 h with different concentrations of the capsular and LPS preparations assayed.
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RESULTS
The batch culturing in a fermentor of mousepassed starting cultures of the two B. fragilis strains NCTC 9343 and ATCC 23745, under constant conditions in a rich medium supplemented with 1% glucose and 10% fetal calf serum, resulted in recoveries of approximately 3 g of bacteria (dry weight) per liter of culture fluid. Under these conditions, an abundant production of capsular polysaccharide took place. The yield of bacteria and capsular polysaccharide was up to 10 times higher than that obtained when culturing was done in flasks without fetal calf serum.
Pelleted bacteria were extracted with hot phenol-water, and the aqueous phase was lyophilized. The material in the aqueous phase was subsequently chromatographed on Sephacryl S-300, using a 3% sodium deoxycholate buffer (Fig. 1) . Three peaks (A, B, and C) were seen with the 9343 extract, and two peaks (A1 and B1) were seen with the 23745 extract, using a refractometer to monitor the effluents. All fractions were also sanned for UV light absorption at 260 nm. Peaks A and C from the 9343 extract and peak B1 from the 23745 extract were heavily contaminated with nucleic acids. The fractions comprising each peak were pooled and precipitated with cold ethanol. The precipitates were collected, dissolved in water, dialyzed against distilled water overnight, and lyophilized. Nucleic acids present in the fractions were removed by nuclease treatment followed by dialysis. The high-molecular-weight material in peak B from the 9343 and in peak Al from the 23745 extract will be referred to as the polysaccharide capsules (for analyses, see below). The yield of the capsular polysaccharide extracted and purified by this method was 35% for the 9343 antigen and 48% for the 23745 antigen (calculated from the crude aqueous phase material).
Analyses of peaks C and B1 from the chromatography on Sephacryl S-300 with 3% sodium deoxycholate showed that these fractions also contained LPS (see below). However, pure LPS could be isolated directly from the lyophilized water phase of the crude phenol-water extract by PCP extraction. The washed, dialyzed, and lyophilized LPSs corresponded to about 10% of the starting material.
Chemical analyses of peak A revealed that this peak contained the capsular polysaccharide together with LPS which had not disaggregated. Additionally, there was nucleic acid present in this peak. The material in this pooled fraction was not studied further.
Chemical (Table 2) . The polysaccharide contained L-fucose, D-galactose, D-glucose, L-quinovosamine, L-fucosamine, L-rhamnosamine, D-glucosamine, and 3-amino-3,6-dideoxyhexose. This capsular polysaccharide also contained galacturonic acid.
The "C nuclear magnetic resonance analyses of the two polysaccharides indicated that most of the aminosugars were N-acetylated.
Immunochemical analyses. The immunochemical specificities of the capsular strains and the LPS preparations from the 9343 and 23745 strains were investigated in inhibition studies with rabbit antisera raised to the purified preparations. In studies involving inhibition of the interaction between LPS from strain 9343 and its corresponding antiserum, the 9343 and 23745 LPS preparations showed almost identical inhibition curves; the concentrations required for 50% inhibition were 0.3 and 0.4 ,g, respectively.
Neither of the two capsular preparations showed any inhibition at 100 ,ug, the highest concentration tested (Fig. 2) . Inhibition studies in which the capsular polysaccharide from strain 9343 was used as coating antigen with the anti-9343 capsular antiserum showed that of the four preparations of polysaccharides and LPSs, only the 9343 capsular preparation was active, with 50%o inhibition at 0.2 ,ug (Fig. 3) . With 100 ,ug of the 23745 capsular preparation, only a 20%o inhibition was observed. When the 23745 capsular polysaccharide antiserum system was used, nisms, and complete separation of these two antigens was uncertain (10, 11, 16) . Subsequent immunization studies demonstrated that the capsular polysaccharide of B. fragilis could induce protective immunity to intraabdominal abscesses formed by Bacteroides species. It was suggested that one explanation for cross-protection was contamination of the capsule with LPS (14). More recently, it was demonstrated that the mechanism by which the capsular polysaccha-
LG INHIBITOR ride of B. fragilis induces immunity depends on 2. ELISA inhibition study on B. fragilis the presence of T cells which have the Ly2+ LPS from 9343 strain was used as coating marker, suggesting a suppressor cell mechanism . The antiserum used was directed against 9343 (23, 26) . Similar studies were not conducted with ,nhibitors: 9343 LPS (0); 23745 LPS (0) . the LPS of these organisms.
Chemical analyses of the capsular polysaccha-3745 capsular preparation caused a 50% ride and LPS of B. fragilis have been difficult tion at 0.3 p.g. A 100-,Lg concentration of because of the large numbers of sugars found 343 capsular preparation gave only 25% and the technical difficulty of completely sepation in this system. Neither of the two LPS rating the capsular polysaccharide from the rations caused any inhibition of the two LPS. Separation difficulties were compounded le-antisera assay systems. By double diffu-by the low yield of cells grown in flasks containn agar, the capsule from strain 23745 gave a ing thioglycolate broth. Another problem was f identity with capsule prepared by previ-that the method of extraction of these antigens nethods when tested against the 23745 from cells, involving an outer membrane isolalar antiserum.
tion procedure, was rather inefficient (10, 11, 16) . DISCUSSION Fermentor growth of B. fragilis strains under controlled conditions with the addition of glune interesting biological features have been cose and fetal calf serum to the medium was a uted to the cell surface polysaccharides of major improvement. These altered growth conzgilis. Earlier studies demonstrated that ditions resulted in yields dry-weight of bacterial :he capsular polysaccharide and the LPS of mass up to threefold higher than those obtained organisms could promote the formation of in flasks without fetal calf serum. Furthermore, sses in an animal model of intraabdominal the initial extraction of organisms with hot phess formation. However, on a stoichiomet-nol-water instead of the outer membrane isolaasis, the capsule was significantly more tion procedure resulted in yields of capsular ive than the LPS in this regard (14, 22) . In polysaccharide which were two to three times studies, it was noted that a number of the higher. Overall, compared with our earlier hydrates found in the capsular polysaccha-growth and isolation methods, the yields of vere also found in the LPS of these orga-antigen were about 10 times higher. A typical 10- liter batch undergoing these growth and extraction methods resulted in 150 mg of capsular polysaccharide, compared with 15 mg under our earlier methods (10, 11, 16) . Chemical analysis of capsular polysaccharides from two prototype strains of B. fragilis revealed that both were essentially free of protein, although the capsule from strain 23745 contained a single amino acid, alanine, in significant amounts. The capsule from strain 9343 contained only trace amounts of amino acids. Amino acids have previously been found as components of polysaccharides (30) . Of course, alanine is also found in the bacterial peptidoglycan (25) . The location of the alanine residue in the 23745 capsular polysaccharide is still unknown.
The finding of nine monosaccharides in the capsular polysaccharide from strain 23745 and of six in that from strain 9343 is unusual, although some components occur in small amounts, and the structural significance is uncertain. The variety and number of sugars suggest that the primary structure of these polysaccharides is complex. Although this material elutes as a single peak off of molecular sieve and ion-exchange columns (15; unpublished data), there is a possibility that more than one polysaccharide species exists in these preparations. Besides the large number of sugar residues, some of the sugars are unusual in bacterial polysaccharides ( Table 2 ). The capsular polysaccharide of strain 9343 contains D-glucosamine and D-and L-quinovosamine. The 23745 capsular polysaccharide contains D-glucosamine, L-quinovosamine, Lrhamnosamine, L-fucosamine, and a 3-amino-3,6-dideoxyhexose. Quinovosamine has been found in Vibrio LPS (9) , but the presence of both the D and L isomers of quinovosamine in the same strain is unique. Rhamnosamine has been found in Escherichia coli LPS (8) , and the D and L isomers of fucosamine have been found in Pseudomonas aeruginosa LPS (2) . It is evident that the structural elucidation of these polysaccharides is a formidable task. In addition, the nuclear magnetic resonance studies show that some, if not all, of the amino sugars are Nacetylated.
The chemical analyses of the LPS preparations from both strains reveal a similar composition of monosaccharides and fatty acids. This result, coupled with the identical immunochemical specificity in ELISA inhibition studies (Fig.  2) (31) . Using these chemical methods for identification of lipids, we have obtained a relatively pure capsular preparation by solubilizing the aqueous phase of a phenol-water extract in 3% sodium deoxycholate. This is done to disaggregate the LPS so that it can be separated from the capsular polysaccharide by Sephacryl S-300 chromatography. Our earlier studies of the capsular polysaccharide and LPS, using 0.5% sodium deoxycholate buffer, resulted in incomplete separation of the two antigens (10, 11, 16) . Even now, despite the improved separation techniques, trace amounts of fatty acids, 1%, were still found in the capsular polysaccharides from both strains, indicating that small amounts of contaminating LPS were present. Although these amounts are insignificant for structural studies, they may cause problems in biological assays. In our hands, pure LPS was most easily obtained by PCP extraction of the crude phenolwater extract. The hydrophobic extraction procedure excluded the coextraction of the capsule. It is interesting to note that PCP extraction of whole, dry B. fragilis bacteria failed to release any LPS (6, 10).
Our earlier investigations showed that B. fragilis strains have a capsular polysaccharide which can be identified morphologically by electron microscopy (12) . Antisera against the earlier preparation of this capsular antigen were found to react with essentially all B. fragilis strains tested in an indirect fluorescent-antibody assay, but they failed to react with strains of other Bacteroides species (3, 12, 28) . As mentioned above, this earlier capsule preparation was found to contain small amounts of contaminating LPS (personal observations). We have now improved upon both the extraction and the separation techniques compared with earlier methods and have better defined the interrelation of these antigens by ELISA inhibition studies. Immunoflourescent studies, using the antisera described in this manuscript, have shown that both capsules and the LPS are surface determinants on B. fragilis strains (A. Weintraub, A. A. Lindberg, and D. L. Kasper, J.
Infect. Dis., in press).. Cross-reactivity between the capsular polysaccharides isolated from each of the two strains was found only at a concentration 10,000 times higher than that of the homologous capsular preparation (Fig. 3) . The two reference strains which both stained with the
